Tripelennamine

DB00792ApprovedVet approvedSmall moleculeHistamine H1 Antagonists

Tripelennamine is a histamine H1 antagonist used to treat hypersensitivity reactions, coughs, and the common cold. A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation.

Chemical structure of Tripelennamine
Mechanism
Curator reviewed
Primary indication
Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.Curator reviewed · 3 structured indications
Formula / weight
C16H21N3 · 255.358 g/mol (avg)
First approval
Canada, 2014
Code names
RP 2750

Resolves to

Compound
UNII3C5ORO99TYCAS91-81-6ChEMBLCHEMBL1241ChEBI9741PubChem5587KEGGC07180
Clinical / RWD
RxNorm10847ATCD04AA04ATCR06AC04PharmGKBPA164764429
Structure
InChIKeyUFLGIAIHIAPJJC-UHFFFAOYSA-NSMILESCN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1
Targets
P35367HRH1

What you can answer from here — as of September 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
279Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
5Marketed productsAcross 2 countries and 4 labellers
Sign in
2ATC codesIncluding every combination product, plus 20 drug categories
Sign in
15+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Tripelennamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In